Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
15-19 January 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
This is a Klimisch 1 OECD 439 guideline study conducted on the registered substance 1-hydroxyoctan-2-one in accordance GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
1-hydroxyoctan-2-one
Cas Number:
7019-19-4
Molecular formula:
C8H16O2
IUPAC Name:
1-hydroxyoctan-2-one
Test material form:
liquid
Details on test material:
Batch 1203/16/100
Specific details on test material used for the study:
Batch 1081-67E

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Justification for test system used:
Initially the predictive capacity of the modified EpiDerm'M Skin Irrit ation Test (SIT) test method, using MatTek EpiDerm™ tissue model EPI-200, underwent full prospective validation from 2003-2007. The test method components of this method were used to define the essential test methods components of the original and updated ECVAM Performance Standards (PS).

A modification of the original EpiDerm'M SIT was validated using the original ECVAM PS in 2008. In 2008, ESAC concluded that the Modified EpiDerm'M SIT has sufficient accuracy and reliability for prediction of R38 skin irritating and no-label (non-skin irritating) test substances.
Vehicle:
unchanged (no vehicle)
Details on test system:
The reconstructed human epidermal model EpiDermTM (EPI-200-MatTek Corporation) consists of normal human-derived epidermal keratinocytes which have been cultured to form a multi-layered highly differentiated model of the human epidermis. It consists of organised basal, spinous and granular layers and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
A single topical application of 30 µl of neat test item, negative control (DPBS) or positive control (SDS 5%) was applied to the surface of EpiDerm™ model
Duration of treatment / exposure:
60 ± 1 minute (25 minutes at room temperature and 35 minutes at 37"C, 5% C02, ≥95% RH)
Duration of post-treatment incubation (if applicable):
42 ± 4h post-treatment incubation, prior to the MTT endpoint
Number of replicates:
Three tissues per condition (Negative Control, Positive Control and Test Item)

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Remarks:
Corrected for freeze killed control tissues
Run / experiment:
1
Value:
4.834
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Irritation / corrosion parameter:
% tissue viability
Remarks:
Uncorrected for freeze killed control tissue
Run / experiment:
1
Value:
8.946
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Other effects / acceptance of results:
The viability of the MTT Interference Control (Freeze Killed Tissues) was 4.112%. Therefore, this value was subtracted from the uncorrected result of 8.946 %viability to yield the corrected result of 4.834% viability.

Any other information on results incl. tables

Viability measurements after 60 min (± 1min) of application and 42h (± 4h) post-incubation of test and reference items and controls.

Condition

Tissue #

Raw data

Blank corrected data

Mean OD

% of Viability

Aliquot 1

Aliquot 2

Aliquot 1

Aliquot 2

NC

Tissue 1

1.767

1.749

1.611

1.593

1.602

106.681

Tissue 2

1.556

1.55

1.400

1.394

1.397

93.030

Tissue 3

1.662

1.662

1.506

1.506

1.506

100.289

PC

Tissue 1

0.258

0.238

0.102

0.082

0.092

6.127

Tissue 2

0.21

0.217

0.054

0.061

0.058

3.829

Tissue 3

0.2

0.209

0.044

0.053

0.049

3.230

TA1

Tissue 1

0.274

0.264

0.118

0.108

0.113

7.525

Tissue 2

0.311

0.31

0.155

0.154

0.155

10.289

Tissue 3

0.291

0.292

0.135

0.136

0.136

9.023

NC: negative control (DPBS), PC: Positive control (SDS 5%), TA1: Test Item

Mean and SD of cell viability measurements and of viability percentages after 60 min (± 1min) of application and 42h (± 4h) post-incubation.

Name

Code

Mean of OD

SD of OD

Mean of viability (%)

SD of viability (%)

CV %

Classification

DPBS

NC

1.502

0.103

100.000

6.830

6.830

Non-Irritant

SDS 5%

PC

0.066

0.023

4.395

1.529

34.791

Irritant

EXPINN PC17032

TA1

0.134

0.021

8.946

1.383

15.465

Irritant

NC: Negative control (DPBS), PC: Positive control (SDS 5%), TA1: Test Item.

Prediction model of irritancy: test items that reduce the viability to 50% or below are irritant (I), test items with a percentage viability above 50% are considered to be non-irritant (NI).

Mean % viabilities obtained from additional tests to correct for MTT interference.

Test Item

MTT Interference Control (FK): % viability

Initial % Viability

Corrected % Viability

TA1

4.112

8.946

4.834

Applicant's summary and conclusion

Interpretation of results:
Category 2 (irritant) based on GHS criteria
Conclusions:
The percentage of viability obtained with the test item was 4.834%, therefore it was considered as Irritant to the skin.
Executive summary:

In vitro assessment of the skin irritation potential of 1 -hydroxyoctan-2 -one was performed according to OECD guideline TG439:In vitroSkin Irritation: Reconstructed Human Epidermis (RHE) Test Method.This in vitro assay predicts the skin irritation potential of a chemical by measurement of its cytotoxic effect on the EpiDerm™ tissue model.The test item is applied directly to the skin surface, providing a good model of “real life” exposure. Cell viability is measured by enzymatic conversion of the vital dye MTT into a blue formazan salt that is quantitatively measured after extraction from the skin tissues. Irritant test items are identified by their ability to decrease cell viability below defined threshold levels (below or equal to 50% for UN GHS Category 2). If the viability is greater than 50%, the test item is classified as Non-Irritant (no-label).

Prior to the execution of the study, the required compatibility checks confirmed that the test item interfered with MTT. Therefore, additional freeze killed tissues were included in order to determine if any direct reduction of MTT had taken place during the main study. No water colouration was observed.

The percentage of viability obtained with the test item 1 -hydroxyoctan-2 –one was 4.834%, therefore it was considered as Irritating to the skin.